Introduction and background on INNCO

innco v5Formed in June 2016, INNCO is the collective voice for the most influential nicotine consumer organisations operating in eleven countries around the world: organisations which each recognise that there are safer ways to enjoy nicotine consumption than tobacco smoking.

There are currently estimated to be over 20.5 million consumers1 who have made an individual choice to switch to what they recognize is a significantly safer choice to combustible tobacco, including e-cigarettes, snus and other novel products.

INNCO aims to represent the views of consumers in promoting safer use of nicotine and to advocate for effective and proportionate regulation of safer nicotine products and their use. Representation includes engagement with international health, regulatory and public health organisations, to ensure that consumers are effectively and equally represented as stakeholders.

INNCO seeks to achieve this through promoting credible science and research into safer nicotine use by increasing global awareness and understanding of the risk reducing and life-saving potential of new technologies.

We seek to ensure, regionally and internationally:

  1. The recognition of the relative safety of smoke free nicotine products.
  2. That there should be no bans on the sale, supply, possession and use of safer forms of smokeless tobacco (e.g. snus), vaping products and E-Liquid containing nicotine, and where currently illegal they should be made legal.
  3. The need to avoid disproportionate regulation on the manufacture, distribution and any (overly) restrictive consumer access to these products
  4. The taxation of lower risk nicotine products as consumer goods, with no tobacco duties or excises applied;
  5. That any restrictions on use in public areas and work spaces are justified on the basis of verifiable evidence
  6. Any decisions made to restrict or limit the use of alternative nicotine products in private premises should be left to individual owners/managers.

It is imperative that the WHO CoP do not directly or covertly seek to legitimize, condone or overlook state imposed regulations which impose iniquitous prohibitions or deny access to safer alternative nicotine products.

INNCO global members support UKCTAS in their critique of the WHO FCTC policy on e-cigarettes.

Today, the International Network of Nicotine Consumer Organisations (INNCO) added its support to a critical report released this morning by leading academics attached to the UK Centre for Tobacco and Alcohol Studies (UKCTAS), in response to the WHO’s FCTC latest report on e-cigarettes (or ENDS as the WHO inexplicably insist on calling them).

The report by the WHO forms the basis for discussions at the forthcoming Conference of the Parties (COP7) in Delhi 7-12 November on the global Framework Convention on Tobacco Control (FCTC). The FCTC’s 180 signatories will decide on future global policy relating to cigarettes and other combustible tobacco products, smokeless tobacco and e-cigarettes.

The last EU meeting to finalise the collective 28-member EU position on e-cigarettes took place earlier this week  in Brussels.

Atakan Befrits, INNCO’s press officer said “Reports suggest the EU statement will  not contain any positive statements on the risk reduction e-cigarettes offer for smokers, despite recent evidence reviews by Public Health England and the Royal College of Physicians that showed enormous benefits for those who switch”..

INNCO called upon all EU Ministers of Health to give immediate attention to the issues raised in the UKCTAS critique of the WHO report, stating -  It is important that the EU collective response to e-cigarettes reflects the positive health benefits conferred on smokers who switch to safer nicotine products and these benefits, as well as potential risks, are assessed objectively.

Judy Gibson, the Steering Group Coordinator of INNCO said “The WHO’s current policy on e-cigarettes is more likely to endanger public health instead of improving it. Once again the WHO remains resolute in refusing to acknowledge scientific evidence and opinions from the world’s leading experts in tobacco addiction. This needs to change - now.”

ENDS

Judy Gibson,

Steering Coordinator INNCO

This email address is being protected from spambots. You need JavaScript enabled to view it.

+447812699615

Notes for editors:

Background on INNCO: Formed in June 2016, INNCO is the collective voice for the most influential nicotine consumer organisations operating in 15 countries around the world: organisations which each recognise that there are safer ways to enjoy nicotine consumption than smoking cigarettes. Further information can be obtained from the website www.innco.org

Note: INNCO operates in full compliance with Article 5.3 of the Framework Convention on Tobacco Control.

● The report ‘Commentary on WHO report on electronic nicotine delivery systems and electronic non-delivery systems can be found here:

http://ukctas.net/news/commentary-on-WHO-report-on-ENDS&ENNDS.html

● The original WHO report to inform the 7th Session of the Conference of the Parties to the WHO Framework Convention on Tobacco Control was published online in August 2016 and can be found here:

http://www.who.int/fctc/cop/cop7/FCTC_COP_7_11_EN.pdf

● The Royal College of Physician’s Report, ‘Nicotine without Smoke’ was published in April 2016 and can be found here: 

https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction-0

Press contact:

Mr Atakan E. Befrits

This email address is being protected from spambots. You need JavaScript enabled to view it.

0046 764 156046

Or use contact from on www.innco.org

To  contact the UKCTAS authors directly:

Media enquiries to:

Professor John Britton, tel: +44 (0)7798 611231email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Professor Linda Bauld tel: +44 (0)7714 213372 email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Professor Ann McNeill tel: +44 (0)7919 057442 email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Dr Ilze Bogdanovica tel +44 (0)1158231381      email: This email address is being protected from spambots. You need JavaScript enabled to view it.